Back

Impact of Impella5.0/5.5 use on short-term prognosis in patients with AMI-related cardiogenic shock receiving Impella-incorporated MCS in Japan

31 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Updates on mechanical circulatory support Cardiogenic Shock ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Makiko Nakamura

University of Toyama, Toyama (Japan)

9 More presentations in this session

Presentation thumbnail
Factors associated with 30-day mortality in patients receiving mechanical circulatory support for cardiogenic shock
Miss M. Bogerd (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Direct comparison of mechanical circulatory support devices in porcine model of acute myocardial infarction complicated by ventricular septal defect and cardiogenic shock
Professor P. Ostadal (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
V-A ECMO weaning with pump-controlled retrograde trial off (PCRTO) approach: an illustration of safety, benefits and feasibility
Doctor F. Fiorelli (London, GB)
Abstract Slides Video
Presentation thumbnail
Association between arterial oxygen tension with clinical outcomes in patients undergoing VA-ECMO support: a systematic review and dose-response meta-analysis
Mr M. Ananta (Central Jakarta, ID)
Abstract Slides Video
Presentation thumbnail
Effectiveness of an Impella versus intra-aortic balloon pump in patients who received extracorporeal membrane oxygenation: a nationwide inpatient database study
Doctor Y. Nishimoto (Toyonaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Updates on mechanical circulatory support

The Event

Event poster

ESC Congress 2024

31 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Short-term outcomes of impella support in japanese patients with cardiogenic shock due to non-ischemic cardiomyopathy
thumbnail
Congress Presentation
Influence of timing of impella insertion on the prognosis of acute myocardial infarction complicated with cardiogenic shock requiring ECPELLA
thumbnail
Congress Presentation
Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources